MDS
New Biomarker Predicts MDS Treatment Response
Researchers have identified a new biomarker to predict treatment response for myelodysplastic syndromes (MDS), ...
MARCH 22, 2022
FDA Approves Reblozyl to Treat Anemia in Some Patients With MDS
The FDA approved luspatercept-aamt (Reblozyl, Celgene) for the treatment of anemia in adults with very low- to ...
APRIL 10, 2020
Load more